24th Dec 2019 09:00
24 December 2019
NMC Health plc
(the "Company" or "NMC")
Trade licenses of Modular Concepts
NMC Health plc (LSE: NMC) announces that, further to the Company's statement on 19 December 2019, it has obtained the trade licenses of Modular Concepts from the 2011-2016 period, stamped copies (along with legal translations) of which have been made available on the Shareholder information section of the Company's Investor Relations page (please see: https://nmc.ae/investorrelations/shareholderinformation). The documents provide the ownership structure of Modular Concepts throughout this period.
Mr. Pradeep Rai manages the Procurement Team responsible for Healthcare Consumables and is not involved in pharma procurement.
Note that the contract for NMC Royal Women's Hospital (formerly Brightpoint) was awarded in 2011. This contract was completed in 2014. Furthermore, construction of all major development projects outlined in its IPO prospectus and undertaken by the Company after its IPO in 2012 were completed by 2015.
Contacts
NMC |
|
Asjad Yahya, Investor Relations | +971 (0)56 219 0975 |
|
|
Media |
|
FTI Consulting, London |
|
Edward Bridges / Simon Conway / Victoria Foster Mitchell | +44 (0)20 3727 1000 |
|
|
FTI Consulting, Gulf |
|
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
NMC is one of the leading private healthcare operators in the Gulf Cooperation Council ("GCC") with an international network of multi-specialty inpatient and outpatient clinics and hospitals, specialized maternity and fertility clinics, and long-term care homes hospitals across nineteen countries. NMC also ranks as one of the top two in-vitro fertilisation operators globally. The NMC Health group is recognised as a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing a selective international expansion programme since 2016, NMC has total capacity of 2,207 licensed beds across its network. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company provides a solid platform for continued growth in the GCC region's largest healthcare market. The NMC Health group treated over 7.5 million patients in 2018. The NMC Health group is also a leading UAE supplier of products and consumables coming from healthcare related products. NMC reported revenues of US$2.1 billion for the year ended 31 December 2018.
In April 2012, NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.
Related Shares:
NMC.L